| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 34.67% | Piper Sandler | $25 → $31 | Maintains | Overweight |
| 11/21/2023 | 12.95% | Raymond James | $23 → $26 | Maintains | Strong Buy |
| 10/25/2023 | -13.12% | Wedbush | $23 → $20 | Maintains | Neutral |
| 10/25/2023 | -0.09% | Raymond James | $28 → $23 | Maintains | Strong Buy |
| 07/31/2023 | 25.98% | Piper Sandler | $28 → $29 | Maintains | Overweight |
| 07/28/2023 | 17.29% | Wedbush | $23 → $27 | Maintains | Neutral |
| 05/01/2023 | 21.63% | Piper Sandler | $33 → $28 | Maintains | Overweight |
| 04/06/2023 | 12.95% | Keefe, Bruyette & Woods | $33 → $26 | Maintains | Market Perform |
| 01/27/2023 | 47.7% | Raymond James | $37 → $34 | Maintains | Strong Buy |
| 07/22/2022 | 60.73% | Raymond James | $35 → $37 | Maintains | Strong Buy |
| 07/07/2022 | 52.04% | Raymond James | $41 → $35 | Upgrades | Outperform → Strong Buy |
| 04/27/2022 | 78.11% | Raymond James | $47 → $41 | Maintains | Outperform |
| 01/25/2022 | — | Stephens & Co. | Downgrades | Overweight → Equal-Weight | |
| 10/07/2021 | 104.17% | Raymond James | $45 → $47 | Downgrades | Strong Buy → Outperform |
| 07/28/2021 | 95.48% | Raymond James | $49 → $45 | Maintains | Strong Buy |
| 05/26/2021 | 108.51% | Wedbush | → $48 | Initiates Coverage On | → Neutral |
| 04/28/2021 | 112.86% | Raymond James | $40 → $49 | Maintains | Strong Buy |
| 01/27/2021 | 73.76% | Raymond James | $30 → $40 | Maintains | Strong Buy |
| 11/04/2020 | — | Stephens & Co. | Reinstates | → Overweight | |
| 10/28/2020 | 30.32% | Raymond James | $25 → $30 | Maintains | Strong Buy |
| 10/01/2020 | 25.98% | Piper Sandler | $31 → $29 | Maintains | Overweight |
| 04/29/2020 | 8.6% | Raymond James | $19 → $25 | Maintains | Outperform |
| 03/25/2020 | 8.6% | Stephens & Co. | → $25 | Upgrades | Equal-Weight → Overweight |
| 01/27/2020 | 39.01% | Stephens & Co. | $33 → $32 | Maintains | Equal-Weight |
| 06/07/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral |
What is the target price for Pacific Premier Bancorp (PPBI)?
The latest price target for Pacific Premier Bancorp (NASDAQ: PPBI) was reported by Piper Sandler on November 21, 2023. The analyst firm set a price target for $31.00 expecting PPBI to rise to within 12 months (a possible 34.67% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pacific Premier Bancorp (PPBI)?
The latest analyst rating for Pacific Premier Bancorp (NASDAQ: PPBI) was provided by Piper Sandler, and Pacific Premier Bancorp maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Pacific Premier Bancorp (PPBI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pacific Premier Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pacific Premier Bancorp was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Pacific Premier Bancorp (PPBI) correct?
While ratings are subjective and will change, the latest Pacific Premier Bancorp (PPBI) rating was a maintained with a price target of $25.00 to $31.00. The current price Pacific Premier Bancorp (PPBI) is trading at is $23.02, which is out of the analyst's predicted range.